QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, August 22, 2007, 27(34):8989-8998; doi:10.1523/JNEUROSCI.1830-07.2007

This Article Full Text Full Text (PDF) Supplemental Data Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Related articles in J. Neurosci. Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Heng, M. Y. Articles by Albin, R. L. Search for Related Content PubMed PubMed Citation Articles by Heng, M. Y. Articles by Albin, R. L.

 Previous Article  |  Next Article 

Neurobiology of Disease
Longitudinal Evaluation of the Hdh^(CAG)150 Knock-In Murine Model of Huntington's Disease

Mary Y. Heng,^1,2 Sara J. Tallaksen-Greene,² Peter J. Detloff,³ and Roger L. Albin^1,2,4

¹Neuroscience Graduate Program and ²Department of Neurology, University of Michigan, Ann Arbor, Michigan 48109, ³Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, Alabama 36294, and ⁴Geriatrics Research, Education, and Clinical Center, Ann Arbor Veterans Administration Medical Center, Ann Arbor, Michigan 48105

Correspondence should be addressed to Dr. Roger L. Albin, 5023 Basic Science Research Building, 109 Zina Pitcher Place, Ann Arbor, MI 48109-2200. Email: ralbin{at}umich.edu

Several murine genetic models of Huntington's disease (HD) have been developed. Murine genetic models are crucial for identifying mechanisms of neurodegeneration in HD and for preclinical evaluation of possible therapies for HD. Longitudinal analysis of mutant phenotypes is necessary to validate models and to identify appropriate periods for analysis of early events in the pathogenesis of neurodegeneration. Here we report longitudinal characterization of the murine Hdh^(CAG)150 knock-in model of HD. A series of behavioral tests at five different time points (20, 40, 50, 70, and 100 weeks) demonstrates an age-dependent, late-onset behavioral phenotype with significant motor abnormalities at 70 and 100 weeks of age. Pathological analysis demonstrated loss of striatal dopamine D₁ and D₂ receptor binding sites at 70 and 100 weeks of age, and stereological analysis showed significant loss of striatal neuron number at 100 weeks. Late-onset behavioral abnormalities, decrease in striatal dopamine receptors, and diminished striatal neuron number observed in this mouse model recapitulate key features of HD. The Hdh^(CAG)150 knock-in mouse is a valid model to evaluate early events in the pathogenesis of neurodegeneration in HD.

Key words: Huntington disease; striatum; neurodegeneration; polyglutamine; trinucleotide repeat; mouse

---

Received April 23, 2007; revised June 21, 2007; accepted June 21, 2007.

Correspondence should be addressed to Dr. Roger L. Albin, 5023 Basic Science Research Building, 109 Zina Pitcher Place, Ann Arbor, MI 48109-2200. Email: ralbin{at}umich.edu

Related articles in J. Neurosci.:

This Week in The Journal

J. Neurosci. 2007 27: i. [Full Text]  

This article has been cited by other articles:

				M. Y. Heng, P. J. Detloff, P. L. Wang, J. Z. Tsien, and R. L. Albin In Vivo Evidence for NMDA Receptor-Mediated Excitotoxicity in a Murine Genetic Model of Huntington Disease J. Neurosci., March 11, 2009; 29(10): 3200 - 3205. [Abstract] [Full Text] [PDF]

				D. E. Ehrnhoefer, S. L. Butland, M. A. Pouladi, and M. R. Hayden Mouse models of Huntington disease: variations on a theme Dis. Model. Mech., March 1, 2009; 2(3-4): 123 - 129. [Abstract] [Full Text] [PDF]

				P. R. Joshi, N.-P. Wu, V. M. Andre, D. M. Cummings, C. Cepeda, J. A. Joyce, J. B. Carroll, B. R. Leavitt, M. R. Hayden, M. S. Levine, et al. Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease J. Neurosci., February 25, 2009; 29(8): 2414 - 2427. [Abstract] [Full Text] [PDF]

				C.-E. Wang, S. Tydlacka, A. L. Orr, S.-H. Yang, R. K. Graham, M. R. Hayden, S. Li, A. W.S. Chan, and X.-J. Li Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease Hum. Mol. Genet., September 1, 2008; 17(17): 2738 - 2751. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help